From nature walks to "forest bathing," Washingtonians are finding ways to reconnect with green spaces in our region.
Guest Host: Jen Golbeck
The chief executive of a pharmaceutical company caused a public outcry when he acquired sole U.S. rights to distribute a lifesaving drug and raised the price by more than 5000 percent. But the issue goes well beyond one company and one former hedge fund manager. A number of companies have been quietly cornering the market on older, off-patent drugs–and hiking prices. We speak with a medical historian about the economics of drug pricing, and why “generic” doesn’t guarantee competition.
- Jeremy Greene MD; Professor of Medicine and the History of Medicine, Johns Hopkins University School of Medicine; Author, “Generic: The Unbranding of Modern Medicine.”
Most Recent Shows
Metro committed to become more reliable and accountable and to build customer confidence. Their General Manager joins us to share how they're doing.
Kojo gets an update on education news in the nation's capital from WAMU's Jenny Abamu.
What's effective in preventing and treating drug abuse? We'll speak to local experts about how they're combating the opioid crisis -- starting with schools.